Canada markets closed

Nascent Biotech, Inc. (NBIO)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.09980.0000 (0.00%)
At close: 09:35AM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-03-31
2022-03-31
2021-03-31
Total Revenue
0
0
1,000
750
Operating Expenses
Research Development
183.414
270.529
197.406
321.938
Selling General and Administrative
1,670
1,502
927.357
1,828
Total Operating Expenses
2,238
2,156
1,457
2,150
Operating Income or Loss
-2,238
-2,156
-457.052
-1,400
Interest Expense
1,091
1,723
335.983
336.632
Total Other Income/Expenses Net
942.836
1,083
473.823
797.644
Income Before Tax
-2,093
-2,801
-470.39
-958.767
Income Tax Expense
-
0
0
0
Income from Continuing Operations
-2,093
-2,801
-470.39
-958.767
Net Income
-2,093
-2,801
-470.39
-958.767
Net Income available to common shareholders
-2,093
-2,801
-470.39
-958.767
Basic EPS
-0.02
-0.02
-0.00
-0.01
Diluted EPS
-0.02
-0.02
-0.00
-0.01
Basic Average Shares
132,544
118,569
107,742
72,342
Diluted Average Shares
132,544
118,569
107,742
72,342